Diabetes

The HCPLive Diabetes condition center page is a comprehensive resource for clinical news and insights on diabetic and cardiometabolic diseases. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for type 1 and type 2 diabetes, as well as related endocrinological conditions and illnesses.

Radiocontrast Exposure Safe for Kidney Function

April 05, 2021

Article

Many believed radiocontrast exposure could be linked to long-term kidney impairment.

Dapagliflozin Benefits Both Men and Women with Heart Failure

March 31, 2021

Article

A subgroup analysis from DAPA-HF show the SGLT2 inhibitor provided efficacy regardless of HFrEF patient gender.

Long-term Semaglutide Leads to Continued Weight Loss Versus Placebo

March 31, 2021

Article

Patients who continued taking semaglutide after an initial 20-week therapy period saw continued weight loss, leading to the hope that a new pharmacologic approach to weight loss could be on the horizon.

Cardiometabolic Risk Evaluation with Brett Nowlan, MD

March 26, 2021

Video

An expert physician in cardiology and metabolic management walks through a presentation on identifying, addressing, and continually treating for heightened cardiometabolic risk.

Semaglutide Helps Curb Obesity, Weight Problems

March 25, 2021

Article

Continuing treatment results in a nearly 8% reduction in weight during a 48 week period.

Anti-Interleukin-21 Antibody with Liraglutide Preserve β-cell Mass in T1D

March 25, 2021

Article

The therapy could offer a therapeutic option with a better safety profile, investigators said.

FDA Approves Dasiglucagon for Severe Hypoglycemia in Diabetic Patients

March 23, 2021

Article

The approval is based on results from Phase 3 trials showing high efficacy in adult and pediatric populations.

Novel Pramlintide & Insulin Combination Therapy Benefits Type 1 Diabetes

March 21, 2021

Article

A single-injection co-formulation of pramlitide and insulin may be a better alternative to separate administrations of both key treatments in adults with T1D, particularly following meals.

Endocrinology Providers, Patients Express High Satisfaction with Telemedicine

March 21, 2021

Article

A majority of surveyed patients and providers want to continue telemedicine follow-up visits after the pandemic ends.

Study Identifies Potential Targets for Prevention of Post-MI Heart Failure

March 21, 2021

Article

Stimulating steroid receptor co-activators may play a role in repairing heart tissue following severe myocardial infarction.